{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T13:52:46Z","timestamp":1753883566679,"version":"3.41.2"},"reference-count":15,"publisher":"The Endocrine Society","issue":"7","license":[{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Multiple myeloma commonly manifests with symptoms arising from the involvement of various organs, particularly the bone and kidneys. In this report, we detail the case of a 44-year-old man who was diagnosed with multiple myeloma associated with reduced bone density. He exhibited clinical findings of osteomalacia due to Fanconi syndrome (characterized clinically by bone pain and proximal weakness and biochemically by elevated serum alkaline phosphatase, hypophosphatemia, hypouricemia, and glucosuria). With phosphate replacement, there was a notable improvement in bone pain, osteomalacia, and bone mineral density. Nevertheless, the patient continued to experience renal wasting of phosphate, uric acid, and glucose despite achieving remission from multiple myeloma for nearly 2 years. Our case highlights several important clinical features of myeloma-associated Fanconi syndrome, including the need to recognize this complication to appropriately treat the underlying bone disease while avoiding osteoclast inhibitors and the long-term persistence of the proximal renal tubulopathy despite achieving remission from myeloma and correction of osteomalacia.<\/jats:p>","DOI":"10.1210\/jcemcr\/luae137","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T02:20:45Z","timestamp":1721874045000},"source":"Crossref","is-referenced-by-count":0,"title":["Long-term Evolution of Hypophosphatemia and Osteomalacia in a Patient With Multiple Myeloma"],"prefix":"10.1210","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3298-0325","authenticated-orcid":false,"given":"Alireza","family":"Zomorodian","sequence":"first","affiliation":[{"name":"Charles and Jane Pak Center for Mineral Metabolism and Clinical Research, University of Texas Southwestern Medical Center , Dallas, TX 75390 , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0997-283X","authenticated-orcid":false,"given":"Naim M","family":"Maalouf","sequence":"additional","affiliation":[{"name":"Charles and Jane Pak Center for Mineral Metabolism and Clinical Research, University of Texas Southwestern Medical Center , Dallas, TX 75390 , USA"},{"name":"Department of Internal Medicine, Division of Endocrinology, University of Texas Southwestern Medical Center , Dallas, TX 75390 , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2024,7,24]]},"reference":[{"issue":"3","key":"2024072409435274400_luae137-B1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0272-6386(97)90207-9","article-title":"Profound hypophosphatemia and isolated hyperphosphaturia in two cases of multiple myeloma","volume":"29","author":"Dash","year":"1997","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"2024072409435274400_luae137-B2","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/ki.1995.421","article-title":"Acute myeloma kidney","volume":"48","author":"Winearls","year":"1995","journal-title":"Kidney Int"},{"issue":"13","key":"2024072409435274400_luae137-B3","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1200\/JCO.2015.65.0044","article-title":"International myeloma working group recommendations for the diagnosis and management of myeloma-related renal impairment","volume":"34","author":"Dimopoulos","year":"2016","journal-title":"J Clin Oncol"},{"issue":"6","key":"2024072409435274400_luae137-B4","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1053\/j.ajkd.2011.12.028","article-title":"Clinicopathologic correlations in multiple myeloma: a case series of 190 patients with kidney biopsies","volume":"59","author":"Nasr","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"2024072409435274400_luae137-B5","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.ajkd.2023.11.011","article-title":"Monoclonal immunoglobulin crystalline membranous nephropathy","volume":"84","author":"Mignano","year":"2024","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"2024072409435274400_luae137-B6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nrneph.2011.168","article-title":"The pathogenesis and diagnosis of acute kidney injury in multiple myeloma","volume":"8","author":"Hutchison","year":"2011","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"2024072409435274400_luae137-B7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s40620-018-0492-4","article-title":"Myeloma light chain cast nephropathy, a review","volume":"32","author":"Sathick","year":"2019","journal-title":"J Nephrol"},{"issue":"2","key":"2024072409435274400_luae137-B8","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.krcp.2014.04.002","article-title":"A case of Fanconi syndrome accompanied by crystal depositions in tubular cells in a patient with multiple myeloma","volume":"33","author":"Kim","year":"2014","journal-title":"Kidney Res Clin Pract"},{"issue":"5","key":"2024072409435274400_luae137-B9","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jbspin.2004.10.012","article-title":"Acquired hypophosphatemic osteomalacia associated with multiple myeloma","volume":"72","author":"Narvaez","year":"2005","journal-title":"Jt Bone Spine"},{"issue":"1","key":"2024072409435274400_luae137-B10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1158\/1078-0432.CCR-18-1537","article-title":"Role of the RANK\/RANKL pathway in multiple myeloma","volume":"25","author":"Raje","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2024072409435274400_luae137-B11","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1600-0609.1997.tb00932.x","article-title":"Abnormal bone turnover in monoclonal gammopathy of undetermined significance: analyses of type I collagen telopeptide, osteocalcin, bone-specific alkaline phosphatase and propeptides of type I and type III procollagens","volume":"58","author":"Vejlgaard","year":"1997","journal-title":"Eur J Haematol"},{"key":"2024072409435274400_luae137-B12","doi-asserted-by":"crossref","first-page":"100338","DOI":"10.1016\/j.jbo.2020.100338","article-title":"Alkaline phosphataselevels in multiple myeloma and solid cancers with bone lesions: is there any difference?","volume":"26","author":"Annibali","year":"2021","journal-title":"J Bone Oncol"},{"issue":"15","key":"2024072409435274400_luae137-B13","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.3390\/cells11152308","article-title":"Bone disease in multiple myeloma: biologic and clinical implications","volume":"11","author":"Bernstein","year":"2022","journal-title":"Cells"},{"issue":"3","key":"2024072409435274400_luae137-B14","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1016\/S1470-2045(20)30559-3","article-title":"Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group","volume":"22","author":"Terpos","year":"2021","journal-title":"Lancet Oncol"},{"issue":"1","key":"2024072409435274400_luae137-B15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4158\/EP.12.1.48","article-title":"Bisphosphonate-induced hypocalcemia: report of 3 cases and review of literature","volume":"12","author":"Maalouf","year":"2006","journal-title":"Endocr Pract"}],"container-title":["JCEM Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/2\/7\/luae137\/58625712\/luae137.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/2\/7\/luae137\/58625712\/luae137.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T02:20:55Z","timestamp":1721874055000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcemcr\/article\/doi\/10.1210\/jcemcr\/luae137\/7718909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,27]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,6,27]]}},"URL":"https:\/\/doi.org\/10.1210\/jcemcr\/luae137","relation":{},"ISSN":["2755-1520"],"issn-type":[{"type":"electronic","value":"2755-1520"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,6,27]]},"article-number":"luae137"}}